Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Moschini

Showing results (421-430 of 561) with videos related to

Pageof 57
Sort By:
Annals of Surgical Oncology|May 27, 2025
Cancer-Specific Mortality of Partial Cystectomy Versus Radical Cystectomy in T2N0M0 Urothelial Bladder CancerMattia Longoni, Andrea Marmiroli, Fabian Falkenbach, et al.
International Urology and Nephrology|February 11, 2025
Key strategies for reducing recurrence in T1 bladder cancer. Evidence from a retrospective multicenter European studyRoberto Contieri, Alexandre Guigui, Bastien Gondran-Tellier, et al.
European Urology Oncology|November 10, 2021
Diagnostic Accuracy of Novel Urinary Biomarker Tests in Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysisEkaterina Laukhtina, Sung Ryul Shim, Keiichiro Mori, et al.
Current Opinion in Urology|November 23, 2021
Features and management of men with pN1 cM0 prostate cancer after radical prostatectomy and lymphadenectomy: a systematic review of population-based evidenceCharles Laine, Giorgio Gandaglia, Massimo Valerio, et al.
Annals of Surgical Oncology|May 17, 2026
Years of Life Lost in Patients with Muscle-Invasive and Metastatic Bladder CancerMattia Longoni, Fabian Falkenbach, Andrea Marmiroli, et al.
Annals of Surgical Oncology|June 29, 2026
ASO Author Reflections: Quantifying the Unseen: Years of Life Lost as a Patient-Centered Metric in Advanced Bladder CancerMattia Longoni, Fabian Falkenbach, Andrea Marmiroli, et al.
The French Journal of Urology|July 8, 2026
Prognostic Impact of Tumor Size in Low-Risk Upper Tract Urothelial Carcinoma: A Multi-Institutional AnalysisEléonore Petit, Idir Ouzaid, Mathieu Roumiguié, et al.
Cancers|December 11, 2022
Oncological Outcomes for Patients Harboring Positive Surgical Margins Following Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Retrospective Multicentric Study on Behalf of the YAU Urothelial GroupGautier Marcq, Luca Afferi, Yann Neuzillet, et al.
Urologic Oncology|July 16, 2021
Incidence, risk factors and outcomes of urethral recurrence after radical cystectomy for bladder cancer: A systematic review and meta-analysisEkaterina Laukhtina, Keiichiro Mori, David D Andrea, et al.
World Journal of Urology|October 4, 2025
Effect of neoadjuvant chemotherapy on years of life lost in radical cystectomy-treated T2N0M0 bladder cancer patientsMattia Longoni, Fabian Falkenbach, Andrea Marmiroli, et al.
Pageof 57

Showing results (421-430 of 561) with videos related to

Sort By:
Pageof 57
Annals of Surgical Oncology|May 27, 2025
Cancer-Specific Mortality of Partial Cystectomy Versus Radical Cystectomy in T2N0M0 Urothelial Bladder CancerMattia Longoni, Andrea Marmiroli, Fabian Falkenbach, et al.
International Urology and Nephrology|February 11, 2025
Key strategies for reducing recurrence in T1 bladder cancer. Evidence from a retrospective multicenter European studyRoberto Contieri, Alexandre Guigui, Bastien Gondran-Tellier, et al.
European Urology Oncology|November 10, 2021
Diagnostic Accuracy of Novel Urinary Biomarker Tests in Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysisEkaterina Laukhtina, Sung Ryul Shim, Keiichiro Mori, et al.
Current Opinion in Urology|November 23, 2021
Features and management of men with pN1 cM0 prostate cancer after radical prostatectomy and lymphadenectomy: a systematic review of population-based evidenceCharles Laine, Giorgio Gandaglia, Massimo Valerio, et al.
Annals of Surgical Oncology|May 17, 2026
Years of Life Lost in Patients with Muscle-Invasive and Metastatic Bladder CancerMattia Longoni, Fabian Falkenbach, Andrea Marmiroli, et al.
Annals of Surgical Oncology|June 29, 2026
ASO Author Reflections: Quantifying the Unseen: Years of Life Lost as a Patient-Centered Metric in Advanced Bladder CancerMattia Longoni, Fabian Falkenbach, Andrea Marmiroli, et al.
The French Journal of Urology|July 8, 2026
Prognostic Impact of Tumor Size in Low-Risk Upper Tract Urothelial Carcinoma: A Multi-Institutional AnalysisEléonore Petit, Idir Ouzaid, Mathieu Roumiguié, et al.
Cancers|December 11, 2022
Oncological Outcomes for Patients Harboring Positive Surgical Margins Following Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Retrospective Multicentric Study on Behalf of the YAU Urothelial GroupGautier Marcq, Luca Afferi, Yann Neuzillet, et al.
Urologic Oncology|July 16, 2021
Incidence, risk factors and outcomes of urethral recurrence after radical cystectomy for bladder cancer: A systematic review and meta-analysisEkaterina Laukhtina, Keiichiro Mori, David D Andrea, et al.
World Journal of Urology|October 4, 2025
Effect of neoadjuvant chemotherapy on years of life lost in radical cystectomy-treated T2N0M0 bladder cancer patientsMattia Longoni, Fabian Falkenbach, Andrea Marmiroli, et al.
Pageof 57